Search

Your search keyword '"Wittner, Ben S."' showing total 267 results

Search Constraints

Start Over You searched for: Author "Wittner, Ben S." Remove constraint Author: "Wittner, Ben S."
267 results on '"Wittner, Ben S."'

Search Results

1. Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells

3. DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs

5. Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product

6. CDKN1B(p27kip1) enhances drug tolerant persister CTCs by restricting polyploidy following mitotic inhibitors

8. COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis

9. Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy

10. HIF1A signaling selectively supports proliferation of breast cancer in the brain

11. Abstract CT073: Efficacy of novel oral SERD elacestrant in fulvestrant-refractory hormone receptor-positive (HR+) breast cancer: a translational investigation

12. Data from A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer

13. Table S2 from The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis

14. Supplementary Tables from A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer

15. Data from AR Expression in Breast Cancer CTCs Associates with Bone Metastases

16. Supplementary figures from A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer

17. Figure S6 from MAPK7 Regulates EMT Features and Modulates the Generation of CTCs

18. Data from The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis

19. Supplementary Tables from AR Expression in Breast Cancer CTCs Associates with Bone Metastases

20. Data from Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer

21. Supplementary Data from The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis

22. Supplementary methods from A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer

23. Supplementary Methods from Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer

24. Supplementary Figures S1 - S10 from AR Expression in Breast Cancer CTCs Associates with Bone Metastases

25. Data from MAPK7 Regulates EMT Features and Modulates the Generation of CTCs

26. Supplementary Tables 1-2 from Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer

27. Supplementary Figures 1-6 from Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer

28. Supplemental Methods, Tables S1-2, Table Legends and Figure Legends from MAPK7 Regulates EMT Features and Modulates the Generation of CTCs

33. RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance

34. Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer

35. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility

36. Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition

38. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

39. Asymmetric cancer cell division regulated by AKT

40. MYC Regulation of a "Poor-Prognosis" Metastatic Cancer Cell State

42. NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancer

43. PROSTATE CANCER: RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance

45. The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis

46. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis

47. CANCER THERAPY: Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility

48. Single cell proteomics of tumor compartments identifies differential kinase activities defining sensitivity to mTOR-PI3-kinase inhibition

49. HER2 expression identifies dynamic functional states within circulating breast cancer cells

50. Abstract 6073: The lipogenic regulatorSREBPinducesTransferrinin circulating melanoma cells, suppressing their susceptibility to ferroptosis

Catalog

Books, media, physical & digital resources